varicella-zoster immune globulin Injection

Brand(s)
Varizig
Category(s)
other
SPL Type(s)
Plasma Derivative
Master SPL
Cangene Biopharma Inc. (2015-08-06)
Oldest Current Product
2015-05-22
License(s)
BLA
RxNORM
INJECTION\VARICELLA-ZOSTER IMMUNE GLOBULIN
SPL Active
INTRAMUSCULAR\LIQUID\HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
SPL Moiety
INTRAMUSCULAR\LIQUID\HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN

product(s) by strength(s)

1.2 ml varicella-zoster immune globulin 100 unt/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1532700126VarizigBLACangene Biopharma Inc.2015-05-22HUMAN VARICELLA-ZOSTER IMMUNE GLOBULININTRAMUSCULARLIQUID125430ac96a331-e2ff-4839-a4d5-fda3d858c969

application(s)

#idtitleapprovedtradenamesfda division
1125430Varicella Zoster Immune Globulin (Human) Application2012-12-20VariZIGCBER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
1ac96a331-e2ff-4839-a4d5-fda3d858c969 (view SPL)These highlights do not include all the information needed to use VARIZIG safely and effectively. See full prescribing information for VARIZIG. VARIZIG [Varicella Zoster Immune Globulin (Human)] for intramuscular administration only. Sterile Solution for Injection Initial U.S. Approval: 2012otherPlasma DerivativeCangene Biopharma Inc.MANUFACTURE2015-08-064532700126

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII